HempFusion Wellness (TSX: CBD.U), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has received USDA Organic Certification for its HempFusion CBD tinctures; the exclusive line of tinctures offers products with potency from 150mg (5mg per serving) to 1,500mg (50mg per serving) of CBD per bottle. HempFusion is one of the first publicly traded CBD companies to receive the certification; the distinction is significant because organic products generally represent some of the highest quality products available. The process to certify its tinctures as USDA Organic started in 2018, and involve providing detailed documentation for every step in the growth, production and manufacturing process of the product ingredients. In addition, HempFusion was required to demonstrate that it met rigorous organic standards regarding it CBD tinctures. The company recently expanded its tincture line to include two new products, designed for consumers who are looking for more CBD per serving. These new products offer 30 and 50mg of CBD per serving or 900 and 1500mg of CBD per bottle, respectively. “Our team has worked meticulously to earn USDA Organic Certification, which supports our commitment to providing consumers with premium and differentiated CBD products as well as new potential distribution points,” said HempFusion co-founder and CEO Jason Mitchell in the press release. “This prestigious certification joins our many other compliance markers, further establishing HempFusion as a leader in the premium CBD category.”
To view the full press release, visit https://cnw.fm/oY2Oh
About HempFusion Wellness Inc.
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in store or online. For more information about the company, visit www.HempFusion.com.
NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://cnw.fm/HempFusion
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
[email protected]
CBDWire is part of the InvestorBrandNetwork.